M Raymond V Finlay

9PUBLICATIONS
43CO-AUTHORS
Biologically active moleculesBiomolecular modelling and designApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 22, 2024
Discovery of (2R,4R)-4-((S)-2-Amino-3-methylbutanamido)-2-(4-boronobutyl)pyrrolidine-2-carboxylic Acid (AZD0011), an Actively Transported Prodrug of a Potent Arginase Inhibitor to Treat Cancer.

Scott N Mlynarski, Brian M Aquila, Susan Cantin

|Nov 14, 2024
Design and Synthesis of Acyclic Boronic Acid Arginase Inhibitors.

Jason D Shields, Brian M Aquila, David Emmons

|Jun 21, 2023
Correction to "Discovery of a Thiadiazole-Pyridazine-Based Allosteric Glutaminase 1 Inhibitor Series That Demonstrates Oral Bioavailability and Activity in Tumor Xenograft Models".

M Raymond V Finlay, Mark Anderton, Andrew Bailey

|Mar 13, 2023
Novel Arginase Inhibitor, AZD0011, Demonstrates Immune Cell Stimulation and Antitumor Efficacy with Diverse Combination Partners.

Aatman S Doshi, Susan Cantin, Marylens Hernandez

|Aug 18, 2022
Optimization of hERG and Pharmacokinetic Properties for Basic Dihydro-8H-purin-8-one Inhibitors of DNA-PK.

Frederick W Goldberg, Attilla K T Ting, David Beattie

|Sep 07, 2021
Potent and Selective Inhibitors of the Epidermal Growth Factor Receptor to Overcome C797S-Mediated Resistance.

M Raymond V Finlay, Peter Barton, Sue Bickerton

Pageof 2

Frequent Collaborators

3 joint publications

Scott N Mlynarski

3 joint publications

Sharon Tentarelli

2 joint publications

J Willem M Nissink

2 joint publications

Peter D Smith